(LYMD) Multi Units France - Lyxor - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: FR0010361683 • India Equity
LYMD: Exchange, Traded, Funds, India, Stocks
‣ Company URL: http://www.amundietf.com ‣ Domicile: France ‣ Index Name: Morningstar India TME NR USD
Additional Sources for LYMD ETF
LYMD ETF Overview
| Market Cap in USD | 711m |
| Category | India Equity |
| TER | 0.85% |
| IPO / Inception | 2006-11-07 |
LYMD ETF Ratings
| Growth 5y | 68.1% |
| Fundamental | - |
| Dividend | - |
| Rel. Strength Industry | -17.4 |
| Analysts | - |
| Fair Price Momentum | 29.02 EUR |
| Fair Price DCF | - |
LYMD Dividends
No Dividends PaidLYMD Growth Ratios
| Growth Correlation 3m | -30.9% |
| Growth Correlation 12m | 58.3% |
| Growth Correlation 5y | 89.9% |
| CAGR 5y | 11.38% |
| CAGR/Mean DD 5y | 1.55 |
| Sharpe Ratio 12m | 0.07 |
| Alpha | -10.56 |
| Beta | 0.53 |
| Volatility | 18.81% |
| Current Volume | 34.2k |
| Average Volume 20d | 19.8k |
What is the price of LYMD stocks?
As of January 30, 2025, the stock is trading at EUR 29.18 with a total of 34,227 shares traded.
Over the past week, the price has changed by -0.38%, over one month by -5.04%, over three months by -6.46% and over the past year by +4.87%.
As of January 30, 2025, the stock is trading at EUR 29.18 with a total of 34,227 shares traded.
Over the past week, the price has changed by -0.38%, over one month by -5.04%, over three months by -6.46% and over the past year by +4.87%.
Is Multi Units France - Lyxor a good stock to buy?
Yes. Based on ValueRay Analyses, Multi Units France - Lyxor (XETRA:LYMD) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 68.06 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LYMD as of January 2025 is 29.02. This means that LYMD is currently overvalued and has a potential downside of -0.55%.
Yes. Based on ValueRay Analyses, Multi Units France - Lyxor (XETRA:LYMD) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 68.06 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LYMD as of January 2025 is 29.02. This means that LYMD is currently overvalued and has a potential downside of -0.55%.
Is LYMD a buy, sell or hold?
Multi Units France - Lyxor has no consensus analysts rating.
Multi Units France - Lyxor has no consensus analysts rating.
What are the forecast for LYMD stock price target?
According to ValueRays Forecast Model, LYMD Multi Units France - Lyxor will be worth about 31.8 in January 2026. The stock is currently trading at 29.18. This means that the stock has a potential upside of +8.84%.
According to ValueRays Forecast Model, LYMD Multi Units France - Lyxor will be worth about 31.8 in January 2026. The stock is currently trading at 29.18. This means that the stock has a potential upside of +8.84%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 31.8 | 8.8% |